To include your compound in the COVID-19 Resource Center, submit it here.

Mithra completes enrollment in Phase II trial of Donesta for vasomotor menopausal symptoms

Mithra Pharmaceuticals S.A. (Euronext:MITRA) completed enrollment of 260 patients with vasomotor menopausal

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE